Neuroone Medical Technologies is trading 19.68% up now at $2.25 amid a broad healthcare-sector rally, with Healthcare (XLV) up 3.23% during regular trading.
- No new company-specific announcement dated August 19, 2026 was identified.
- The latest catalyst remains the August 13 earnings update, showing 43% year-over-year order growth.
- Manufacturing constraints limited recognized-revenue guidance to $9.2 million-$10.5 million.